And the inhibition of DGAT1 in PA-treated cells would increase C16 ceramide which induced tumor growth while C18 ceramide did not11,55, inferring that inhibition of PA-induced LDs may lead to a worse outcome in treating gliomas. This evidence concerns the gene DGAT1 and central nervous system cancer.